Health Highlights: July 14, 2022

No rise in methadone ODs in pandemic, supporting use as at-home treatment. COVID crisis forced many opioid treatment centers to close, but addicts safely took the treatment at home, a new study finds. Read more
FDA approves Novavax as 4th COVID-19 vaccine. The two-dose vaccine employs nanoparticle technology to trigger an immune response, so it might be seen as alternative to mRNA-based shots from Pfizer or Moderna, experts say. Read more
Pharmacies must fill prescriptions for abortion meds, feds say. Failing to do so risks violating federal civil rights law barring sex discrimination, the Biden administration said on Wednesday. Read more
Demand is overwhelming NYC's effort to roll out monkeypox vaccine. The appointment system aimed at streamlining access to the vaccine crashed in America's largest city, one of many places where supplies have been running out almost as soon as they arrive. Read more
Cancer drug might be powerful treatment against multiple sclerosis. The drug, rituximab, is already used "off-label" for MS and is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. Read more
Asthma drug fails as potential COVID treatment. Despite hopes that the medicine might help, researchers found "no evidence" that fluticasone kept folks with mild-to-moderate COVID out of the hospital. Read more
Was this page helpful?
Related Posts
Los refuerzos contra la COVID para las variantes más recientes podrían estar listos tras el Día del Trabajo
MIÉRCOLES, 24 de agosto de 2022 (HealthDay News) -- La Administración de Biden...
Scientists Use Stem Cells to Replicate Early Human Embryo
FRIDAY, June 30, 2023 (HealthDay News) – Scientists hope to learn more about the...
Los bebés de las madres que tuvieron COVID en el embarazo no sufren problemas de salud
MARTES, 21 de diciembre de 2021 (HealthDay News) -- Las mamás que tuvieron...
Pfizer afirma que su dosis de refuerzo mejora la respuesta inmunitaria en los niños de 5 a 11 años
JUEVES, 14 de abril de 2022 (HealthDay News) -- Pfizer Inc. afirmó el jueves que...
